DICER1 and nonpapillary renal cell carcinoma: To investigate whether Dicer expression levels correlate with VHL-deficient ccRCC patient survival, we followed up with 146 ccRCC patients with VHL mutations or promoter methylation for 1–52 months (median, 39 months).